271 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GJB2Gap junction protein, beta 2, 26kDaDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GJC3Gap junction protein, gamma 3, 30.2kDaPredicted membrane proteins
Transporters
Tissue enhanced
GLRA1Glycine receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor, alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
GLRA3Glycine receptor, alpha 3FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GLRBGlycine receptor, betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GNLYGranulysinPredicted intracellular proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRIA2Glutamate receptor, ionotropic, AMPA 2Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GRIA3Glutamate receptor, ionotropic, AMPA 3Disease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRIK4Glutamate receptor, ionotropic, kainate 4Predicted membrane proteins
Transporters
Tissue enhanced
GRIN1Glutamate receptor, ionotropic, N-methyl D-aspartate 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
Tissue enriched
GRIN2CGlutamate receptor, ionotropic, N-methyl D-aspartate 2CFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
HCN2Hyperpolarization activated cyclic nucleotide-gated potassium channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
HCN4Hyperpolarization activated cyclic nucleotide-gated potassium channel 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
HPXHemopexinCandidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Transporters
Tissue enriched
HSPA1AHeat shock 70kDa protein 1ACancer-related genes
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Transporters
Expressed in all
HSPA1BHeat shock 70kDa protein 1BCancer-related genes
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Transporters
Expressed in all
HTN3Histatin 3Predicted secreted proteins
Transporters
Tissue enriched
HTR3A5-hydroxytryptamine (serotonin) receptor 3A, ionotropicFDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HTR3D5-hydroxytryptamine (serotonin) receptor 3D, ionotropicPredicted membrane proteins
Transporters
Not detected
HVCN1Hydrogen voltage-gated channel 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ITPR1Inositol 1,4,5-trisphosphate receptor, type 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Mixed
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium voltage-gated channel, subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium voltage-gated channel, subfamily H (eag-related), member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ13Potassium inwardly-rectifying channel, subfamily J, member 13Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ16Potassium inwardly-rectifying channel, subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ2Potassium inwardly-rectifying channel, subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ3Potassium inwardly-rectifying channel, subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ5Potassium inwardly-rectifying channel, subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ6Potassium inwardly-rectifying channel, subfamily J, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium inwardly-rectifying channel, subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK16Potassium channel, subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNK17Potassium channel, subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK3Potassium channel, subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK5Potassium channel, subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK6Potassium channel, subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNN2Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ3Potassium voltage-gated channel, KQT-like subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched

« prev | Page of 6 | next »